Market Cap 75.76M
Revenue (ttm) 0.00
Net Income (ttm) -22.45M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 81,594
Avg Vol 253,994
Day's Range N/A - N/A
Shares Out 14.54M
Stochastic %K 75%
Beta -0.90
Analysts Strong Sell
Price Target $23.00

Company Profile

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In...

Industry: Biotechnology
Sector: Healthcare
Phone: 913 942 2300
Address:
1901 West 47th Place, Kansas City, United States
Max100565
Max100565 Aug. 16 at 7:29 PM
$CING I asked Gemini if ​​they have started production.
0 · Reply
ZacksResearch
ZacksResearch Aug. 14 at 7:27 PM
$CING has cash into mid-2027 — but the FDA path still holds the key. ⚠️ Cingulate had $28.4M in cash as of June 30, 2026, while CTx-1301’s NDA resubmission work continues after the FDA’s June 1 Complete Response Letter. 🔬 CMC work underway 💰 Cash runway into mid-2027 📜 New CTx-1301 patent protects key aspects through December 2042 🚀 Commercialization preparations advancing, contingent upon FDA approval Find more on CING here👉 https://www.zacks.com/stock/quote/CING?cid=sm-stocktwits-0-price_target-oc-39265&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_39265
0 · Reply
biotechs2021
biotechs2021 Aug. 14 at 6:17 PM
$CING not selling. Bring it to 0.
0 · Reply
stockpurrrrs
stockpurrrrs Aug. 14 at 3:16 PM
$CING just bought 2000 more on the dip thank you
0 · Reply
BimmernutZ
BimmernutZ Aug. 14 at 2:02 PM
$CING Last shakeout for weak hands before $6 and upwards, hang tight
1 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Aug. 14 at 12:44 AM
$CAPR $REPL $SLS Don't forget $CING !!!
1 · Reply
Merlintrader
Merlintrader Aug. 13 at 8:38 PM
Cingulate Inc. ($CING) Stock Hub 2026 Q2 https://www.merlintrader.com/cingulate-inc-stock-hub/
0 · Reply
Laacy
Laacy Aug. 13 at 4:19 PM
$AC.TSX oh fuck it back on for long term. Can average down if needed. Long this $CING $LAC $LAR long term. At least I made money while out o fthis
1 · Reply
Wise_Wizard
Wise_Wizard Aug. 13 at 3:48 PM
$CING They trying to scoop up shares via stop losses with this price action
0 · Reply
Spicy_Weeklies
Spicy_Weeklies Aug. 13 at 2:59 PM
$CING A close above $5 wouldn’t be a surprise with this spread. Nice opportunity today.
0 · Reply
Latest News on CING
Cingulate Earnings release: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

Cingulate Earnings release: Q2 2026


Cingulate Quarterly report: Q2 2026

Aug 13, 2026, 8:30 AM EDT - 6 days ago

Cingulate Quarterly report: Q2 2026


Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®

Jul 2, 2026, 8:30 AM EDT - 6 weeks ago

Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®


Cingulate issues patent by USPTO for CTx-1301

2026-06-16T12:17:17.000Z - 2 months ago

Cingulate issues patent by USPTO for CTx-1301


Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Jun 16, 2026, 8:00 AM EDT - 2 months ago

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301


Cingulate issued complete response letter for CTx-1301 from FDA

2026-06-02T13:17:58.000Z - 2 months ago

Cingulate issued complete response letter for CTx-1301 from FDA


US FDA declines to approve Cingulate's ADHD drug

Jun 2, 2026, 8:08 AM EDT - 2 months ago

US FDA declines to approve Cingulate's ADHD drug


Cingulate Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 2 months ago

Cingulate Proxy statement: Proxy filing


Cingulate Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 2 months ago

Cingulate Proxy statement: Proxy filing


Cingulate price target lowered to $10 from $14 at Roth Capital

2026-05-19T15:00:40.000Z - 3 months ago

Cingulate price target lowered to $10 from $14 at Roth Capital


Cingulate Proxy statement: Proxy filing

May 18, 2026, 8:00 AM EDT - 3 months ago

Cingulate Proxy statement: Proxy filing


Cingulate Earnings release: Q1 2026

May 14, 2026, 8:00 AM EDT - 3 months ago

Cingulate Earnings release: Q1 2026


Cingulate Quarterly report: Q1 2026

May 14, 2026, 8:00 AM EDT - 3 months ago

Cingulate Quarterly report: Q1 2026


Cingulate Registration statement: Registration filing

Apr 14, 2026, 8:00 AM EDT - 4 months ago

Cingulate Registration statement: Registration filing


Cingulate Slides: Corporate presentation

Apr 1, 2026, 7:00 AM EDT - 5 months ago

Cingulate Slides: Corporate presentation


Cingulate Registration statement: Registration filing

Mar 23, 2026, 8:00 AM EDT - 5 months ago

Cingulate Registration statement: Registration filing


Cingulate price target lowered to $14 from $16 at Roth Capital

2026-03-22T22:30:08.000Z - 5 months ago

Cingulate price target lowered to $14 from $16 at Roth Capital


Cingulate Registration statement: Registration filing

Mar 20, 2026, 8:00 AM EDT - 5 months ago

Cingulate Registration statement: Registration filing


Cingulate files to sell 3.5M shares of common stock for holders

2026-03-20T11:46:09.000Z - 5 months ago

Cingulate files to sell 3.5M shares of common stock for holders


Cingulate announces U.S. patent notice of allowance

2026-03-18T12:12:11.000Z - 5 months ago

Cingulate announces U.S. patent notice of allowance


Cingulate reports Q4 net loss $6.3M vs. $6.2M last year

2026-03-18T12:05:55.000Z - 5 months ago

Cingulate reports Q4 net loss $6.3M vs. $6.2M last year


Cingulate sees cash runway into late 4Q26

2026-03-18T12:05:40.000Z - 5 months ago

Cingulate sees cash runway into late 4Q26


Cingulate Proxy statement: Proxy Filing

Mar 18, 2026, 8:00 AM EDT - 5 months ago

Cingulate Proxy statement: Proxy Filing


Cingulate Earnings release: Q4 2025

Mar 18, 2026, 7:00 AM EDT - 5 months ago

Cingulate Earnings release: Q4 2025


Cingulate Annual report: Q4 2025

Mar 18, 2026, 7:00 AM EDT - 5 months ago

Cingulate Annual report: Q4 2025


Why did Cingulate stock skyrocket today?

Mar 16, 2026, 1:26 PM EDT - 5 months ago

Why did Cingulate stock skyrocket today?


Cingulate Proxy statement: Proxy Filing

Mar 2, 2026, 7:00 AM EST - 6 months ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Feb 18, 2026, 7:00 AM EST - 6 months ago

Cingulate Proxy statement: Proxy Filing


Cingulate files $200M mixed securities shelf

2026-01-12T22:15:20.000Z - 7 months ago

Cingulate files $200M mixed securities shelf


Cingulate Registration statement: Registration Filing

Jan 12, 2026, 7:00 AM EST - 7 months ago

Cingulate Registration statement: Registration Filing


Cingulate price target lowered to $16 from $17 at Roth Capital

2025-11-19T12:40:10.000Z - 9 months ago

Cingulate price target lowered to $16 from $17 at Roth Capital


Cingulate price target lowered to $16 from $17 at Roth Capital

2025-11-19T00:55:07.000Z - 9 months ago

Cingulate price target lowered to $16 from $17 at Roth Capital


Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year

2025-11-13T13:16:41.000Z - 9 months ago

Cingulate reports Q3 net loss ($7.3M) vs ($4.1M) last year


Cingulate Quarterly report: Q3 2025

Nov 13, 2025, 8:00 AM EST - 9 months ago

Cingulate Quarterly report: Q3 2025


Cingulate Earnings release: Q3 2025

Nov 13, 2025, 8:00 AM EST - 9 months ago

Cingulate Earnings release: Q3 2025


Cingulate names Downey as CCO to lead launch prep for CTx-1301

2025-11-10T13:25:38.000Z - 10 months ago

Cingulate names Downey as CCO to lead launch prep for CTx-1301


Cingulate price target raised to $17 from $10 at Roth Capital

2025-10-15T01:25:08.000Z - 11 months ago

Cingulate price target raised to $17 from $10 at Roth Capital


Cingulate Quarterly report: Q2 2025

Aug 19, 2025, 7:00 AM EDT - 1 year ago

Cingulate Quarterly report: Q2 2025


Cingulate Earnings release: Q2 2025

Aug 19, 2025, 7:00 AM EDT - 1 year ago

Cingulate Earnings release: Q2 2025


Cingulate Provides Management Team Update

Aug 15, 2025, 9:00 AM EDT - 1 year ago

Cingulate Provides Management Team Update


Cingulate Proxy statement: Proxy Filing

Aug 15, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

Jul 25, 2025, 8:00 AM EDT - 1 year ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Jul 22, 2025, 8:00 AM EDT - 1 year ago

Cingulate Registration statement: Registration Filing


Cingulate Earnings release: Q1 2025

May 8, 2025, 12:00 AM EDT - 1 year ago

Cingulate Earnings release: Q1 2025


Cingulate Quarterly report: Q1 2025

May 8, 2025, 12:00 AM EDT - 1 year ago

Cingulate Quarterly report: Q1 2025


Cingulate Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Cingulate Proxy statement: Proxy Filing


Cingulate Annual report: Q4 2024

Mar 26, 2025, 9:00 AM EDT - 1 year ago

Cingulate Annual report: Q4 2024


Cingulate Earnings release: Q4 2024

Mar 26, 2025, 9:00 AM EDT - 1 year ago

Cingulate Earnings release: Q4 2024


Cingulate Quarterly report: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Cingulate Quarterly report: Q3 2024


Cingulate Earnings release: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Cingulate Earnings release: Q3 2024


Cingulate Registration statement: Registration Filing

Oct 7, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Oct 3, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Sep 27, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Sep 12, 2024, 8:30 AM EDT - 2 years ago

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301


Cingulate to Participate in Benzinga All Live Access Event

Aug 27, 2024, 4:30 PM EDT - 2 years ago

Cingulate to Participate in Benzinga All Live Access Event


Cingulate Announces Adjournment of Special Meeting

Aug 23, 2024, 4:45 PM EDT - 2 years ago

Cingulate Announces Adjournment of Special Meeting


Cingulate Proxy statement: Proxy Filing

Aug 23, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

Aug 19, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Quarterly report: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

Cingulate Quarterly report: Q2 2024


Cingulate Earnings release: Q2 2024

Aug 13, 2024, 7:00 AM EDT - 2 years ago

Cingulate Earnings release: Q2 2024


Cingulate Proxy statement: Proxy Filing

Jul 22, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

Jul 15, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Proxy statement: Proxy Filing

Jul 12, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Jul 12, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Jun 28, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Jun 18, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Registration statement: Registration Filing

May 17, 2024, 8:00 AM EDT - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Quarterly report: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Cingulate Quarterly report: Q1 2024


Cingulate Earnings release: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

Cingulate Earnings release: Q1 2024


Cingulate Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Annual report: Q4 2023

Apr 1, 2024, 7:00 AM EDT - 2 years ago

Cingulate Annual report: Q4 2023


Cingulate Earnings release: Q4 2023

Apr 1, 2024, 7:00 AM EDT - 2 years ago

Cingulate Earnings release: Q4 2023


Cingulate to Attend DCAT Week 2024 in New York City

Mar 6, 2024, 6:45 AM EST - 2 years ago

Cingulate to Attend DCAT Week 2024 in New York City


Cingulate Announces Closing of $7.5 Million Public Offering

Feb 6, 2024, 4:15 PM EST - 2 years ago

Cingulate Announces Closing of $7.5 Million Public Offering


Cingulate Announces Pricing of $7.5 Million Public Offering

Feb 2, 2024, 9:15 AM EST - 2 years ago

Cingulate Announces Pricing of $7.5 Million Public Offering


Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

Jan 29, 2024, 8:00 AM EST - 2 years ago

Longtime Cingulate Controller Jennifer Callahan Promoted to CFO


Cingulate Registration statement: Registration Filing

Jan 29, 2024, 7:00 AM EST - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Jan 12, 2024, 7:00 AM EST - 2 years ago

Cingulate Registration statement: Registration Filing


Cingulate Registration statement: Registration Filing

Nov 15, 2023, 7:00 AM EST - 3 years ago

Cingulate Registration statement: Registration Filing


Cingulate Quarterly report: Q3 2023

Nov 13, 2023, 7:00 AM EST - 3 years ago

Cingulate Quarterly report: Q3 2023


Cingulate Earnings release: Q3 2023

Nov 13, 2023, 7:00 AM EST - 3 years ago

Cingulate Earnings release: Q3 2023


Cingulate to Host CNS Key Opinion Leader Panel in New York City

Oct 17, 2023, 2:22 PM EDT - 3 years ago

Cingulate to Host CNS Key Opinion Leader Panel in New York City


Cingulate Proxy statement: Proxy Filing

Oct 2, 2023, 8:00 AM EDT - 3 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Proxy statement: Proxy Filing

Sep 22, 2023, 8:00 AM EDT - 3 years ago

Cingulate Proxy statement: Proxy Filing


Cingulate Inc. to Present at the LD Micro Main Event XVI

Sep 21, 2023, 1:30 PM EDT - 3 years ago

Cingulate Inc. to Present at the LD Micro Main Event XVI


Cingulate Inc. To Present at the LD Micro Main Event XVI

Sep 21, 2023, 11:23 AM EDT - 3 years ago

Cingulate Inc. To Present at the LD Micro Main Event XVI


Max100565
Max100565 Aug. 16 at 7:29 PM
$CING I asked Gemini if ​​they have started production.
0 · Reply
ZacksResearch
ZacksResearch Aug. 14 at 7:27 PM
$CING has cash into mid-2027 — but the FDA path still holds the key. ⚠️ Cingulate had $28.4M in cash as of June 30, 2026, while CTx-1301’s NDA resubmission work continues after the FDA’s June 1 Complete Response Letter. 🔬 CMC work underway 💰 Cash runway into mid-2027 📜 New CTx-1301 patent protects key aspects through December 2042 🚀 Commercialization preparations advancing, contingent upon FDA approval Find more on CING here👉 https://www.zacks.com/stock/quote/CING?cid=sm-stocktwits-0-price_target-oc-39265&ADID=SYND_STOCKTWITS_TWEET_0_PRICETARGET_OC_39265
0 · Reply
biotechs2021
biotechs2021 Aug. 14 at 6:17 PM
$CING not selling. Bring it to 0.
0 · Reply
stockpurrrrs
stockpurrrrs Aug. 14 at 3:16 PM
$CING just bought 2000 more on the dip thank you
0 · Reply
BimmernutZ
BimmernutZ Aug. 14 at 2:02 PM
$CING Last shakeout for weak hands before $6 and upwards, hang tight
1 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Aug. 14 at 12:44 AM
$CAPR $REPL $SLS Don't forget $CING !!!
1 · Reply
Merlintrader
Merlintrader Aug. 13 at 8:38 PM
Cingulate Inc. ($CING) Stock Hub 2026 Q2 https://www.merlintrader.com/cingulate-inc-stock-hub/
0 · Reply
Laacy
Laacy Aug. 13 at 4:19 PM
$AC.TSX oh fuck it back on for long term. Can average down if needed. Long this $CING $LAC $LAR long term. At least I made money while out o fthis
1 · Reply
Wise_Wizard
Wise_Wizard Aug. 13 at 3:48 PM
$CING They trying to scoop up shares via stop losses with this price action
0 · Reply
Spicy_Weeklies
Spicy_Weeklies Aug. 13 at 2:59 PM
$CING A close above $5 wouldn’t be a surprise with this spread. Nice opportunity today.
0 · Reply
bullshit911
bullshit911 Aug. 13 at 2:55 PM
$CING Bro, did you read the filing or just the red candle? 😂 The CRL was in June. Nobody expected FDA approval in Q2. What matters is that Cingulate confirmed it is already manufacturing CTx-1301 process validation batches with Bend — one of the final major CMC steps before resubmission. They also have $28.4M cash, runway into mid-2027, Prasco for distribution, Indegene for commercialization, IQVIA for sales, and the CRL did not raise safety or efficacy concerns. Could it hit $4 short term? Sure, it’s a microcap. But an 8% drop doesn’t mean the thesis is broken. The real catalyst is validation complete → NDA resubmission → new FDA review clock. Come back when validation fails. Until then, you’re just trading candles. 😂
0 · Reply
BimmernutZ
BimmernutZ Aug. 13 at 2:48 PM
$CING Who the fuck is selling at these prices, this company will make millions in few quarters
2 · Reply
activehybrid
activehybrid Aug. 13 at 2:11 PM
$CING oh oh ! Did I hurt some people’s fragile feelings ? Dude , look at the 8 percent decrease after q2 release and no real fda approval This will definitely get $4 and below Sorry sunshine princess but short term looks bearish
0 · Reply
activehybrid
activehybrid Aug. 13 at 1:11 PM
$CING q2 released but no real road map to submit fda approval This could take 12-18 months
0 · Reply
TwongStocks
TwongStocks Aug. 13 at 12:57 PM
$CING 10-Q filed https://www.sec.gov/ix?doc=/Archives/edgar/data/1862150/000149315226037606/form10-q.htm • 14,541,826 shares outstanding as of Aug 12 • In Q2, they sold 806,893 shares under the ATM for net proceeds of $4,347,364. • In Q2, they sold 1,032,372 shares under the Lincoln Park Purchase Agreement for net proceeds of $5,058,975. • Subsequent Events: After June 30, they exchanged $1,320,000 in principal from the Avondale note into 139,751 shares & a cash payment of $600K; they sold sold 220,476 shares under the 2025 LP Purchase Agreement for net proceeds of $1,068,525; and they sold 271,717 shares under the ATM for net proceeds of $1,394,179.
0 · Reply
focafoca99
focafoca99 Aug. 13 at 12:53 PM
$CING cited its June quarter results in a fresh press release.
0 · Reply
STACKD0E
STACKD0E Aug. 13 at 12:38 PM
0 · Reply
TwongStocks
TwongStocks Aug. 13 at 12:32 PM
$CING Cingulate Inc. Reports Second Quarter 2026 Financial Results and Provides Update on CTx-1301 CMC Progress Towards NDA Resubmission and Commercial Readiness https://www.cingulate.com/news-releases/news-release-details/cingulate-inc-reports-second-quarter-2026-financial-results-and • As of June 30, 2026 , Cingulate had approximately $28.4 million in cash and cash equivalents • Cingulate continues to make progress on the CMC work needed to support resubmission of the NDA for CTx-1301 (dexmethylphenidate HCl), its lead ADHD asset. The Company is working closely with its manufacturing partner to complete this work and plans to resubmit the NDA to the FDA as promptly as practicable.
0 · Reply
Hrk024
Hrk024 Aug. 11 at 5:30 PM
$CING @activehybrid Lot of chatter from you lately on here. More than needed. You have to be getting scared at this point. I hate to say it, but all your concerns are priced in and have been. Time to hedge with some nice calls 😎
4 · Reply
aak12345
aak12345 Aug. 11 at 3:10 PM
$CING PR like today might look fluff but really important for adaption once we get an approval
1 · Reply
activehybrid
activehybrid Aug. 11 at 2:26 PM
$CING no update for fda meeting in q2 !! This is really bad than most people think I strongly believe $4 for sure , $3 depends on fda update Management plays death fish but super smart people say there’s no reason worry
3 · Reply
Jumpingfox
Jumpingfox Aug. 11 at 1:56 PM
$CING Does anyone have pages 2 and 3 of Form 483?
0 · Reply